BAUSCH HEALTH COMPAN

BHC
Delayed Quote. Delayed  - 06/24 04:10:00 pm
29.71USD +2.17%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2020 2021
Net sales1 8 0278 611
EBITDA1 3 2943 450
Operating profit (EBIT)1 2 9593 137
Operating Margin 36,9%36,4%
Pre-Tax Profit (EBT)1 -934-679
Net income1 -560-719
Net margin -6,98%-8,35%
EPS2 -1,58-1,92
Dividend per Share2 --
Announcement Date 02/24/2021-
1 USD in Million
2 USD
Finances - Leverage
Fiscal Period: December 2020 2021
Net Debt1 22 10921 594
Net Cash position1 --
Leverage (Debt / EBITDA) 6,71x6,26x
Free Cash Flow1 8092 401
ROE (Net Profit / Equities) 179%-1 280%
Shareholders' equity1 -31356,2
ROA (Net Profit / Asset) 4,39%2,02%
Assets1 -12 757-35 566
Book Value Per Share 1,51-
Cash Flow per Share2 3,131,14
Capex1 302277
Capex / Sales 3,76%3,22%
Announcement Date 02/24/2021-
1 USD in Million
2 USD
Financial Ratios
Size 2021e 2022e
Capitalization 10 422 M $ -
Entreprise Value (EV) 32 016 M $ 30 490 M $
Valuation 2021e 2022e
P/E ratio (Price / EPS) -15,1x 30,6x
Capitalization / Revenue 1,21x 1,16x
EV / Revenue 3,72x 3,57x
EV / EBITDA 9,28x 8,82x
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2021e 2022e
Operating Margin (EBIT / Sales) 36,4% 36,9%
Operating Leverage (Delta EBIT / Delta Sales) 0,83x 1,31x
Net Margin (Net Profit / Revenue) -8,35% 2,79%
ROA (Net Profit / Asset) 2,02% 4,32%
ROE (Net Profit / Equities) -1 280% -
Rate of Dividend - -
Balance Sheet Analysis 2021e 2022e
CAPEX / Sales   3,22% 2,97%
Cash Flow / Sales 4,75% 20,9%
Capital Intensity (Assets / Sales) -4,13x 0,65x
Financial Leverage (Net Debt / EBITDA) 6,26x 5,53x
Price Earning Ratio
EPS & Dividend